The Drug Price Restriction lets multinational companies walk away on investments in the Korean market

Although multinational companies are actively investing on the Asian market, it is known that they have avoided the Korean market.

The reason was indicated to the excessive drug price reduction policy.

According to the Korean Research-based Pharma Industry Association’s (KRPIA) report titled the ‘Improvement Plan for Drug Price Policy to Develop the Pharmaceutical Industry and Increase Patent...